Publications by authors named "Andrew Ferretti"

Article Synopsis
  • Some people with advanced lung cancer don't get better even after treatment, but one patient did really well for over 8 years after treatment with a special medicine and radiation.
  • This patient had a special kind of immune cells (T cells) that grew a lot after treatment, which might have helped the body fight the cancer better.
  • Scientists think the combination of radiation therapy before the other treatment and the way these T cells grew helped this patient have a better response to fighting the cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Neoadjuvant immune checkpoint blockade is a treatment that helps the body's immune system fight oral cancer and has shown good results in patients.
  • In a study, scientists found that specific immune cells called CD8 T cells became more active and ready to attack the cancer right before and during treatment.
  • The treatment not only boosted the immune response in the tumors but also in the blood, creating more activated T cells which were important for fighting the cancer.
View Article and Find Full Text PDF

Protein phosphatase 2A (PP2A) composed of a scaffold subunit, a catalytic subunit, and multiple regulatory subunits is a ubiquitously expressed serine/threonine phosphatase. We have previously shown that the PP2A catalytic subunit is increased in T cells from patients with systemic lupus erythematosus and promotes IL-17 production by enhancing the activity of Rho-associated kinase (ROCK) in T cells. However, the molecular mechanism whereby PP2A regulates ROCK activity is unknown.

View Article and Find Full Text PDF

Developing effective strategies to prevent or treat coronavirus disease 2019 (COVID-19) requires understanding the natural immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used an unbiased, genome-wide screening technology to determine the precise peptide sequences in SARS-CoV-2 that are recognized by the memory CD8 T cells of COVID-19 patients. In total, we identified 3-8 epitopes for each of the 6 most prevalent human leukocyte antigen (HLA) types.

View Article and Find Full Text PDF

Protein phosphatase 2A is a ubiquitously expressed serine/threonine phosphatase that comprises a scaffold, a catalytic, and multiple regulatory subunits and has been shown to be important in the expression of autoimmunity. We considered that a distinct subunit may account for the decreased production of IL-2 in people and mice with systemic autoimmunity. We show that the regulatory subunit PPP2R2D is increased in T cells from people with systemic lupus erythematosus and regulates IL-2 production.

View Article and Find Full Text PDF

To address the problem of poor asthma control due to drug resistance, an antisense oligonucleotide complementary to mmu-miR-145a-5p (antimiR-145) was tested in a house dust mite mouse model of mild/moderate asthma. miR-145 was targeted to reduce inflammation, regulate epithelial-mesenchymal transitions, and promote differentiation of structural cells. In addition, several chemical variations of a nontargeting oligonucleotide were tested to define sequence-dependent effects of the miRNA antagonist.

View Article and Find Full Text PDF

Calcium calmodulin kinase IV (CaMK4) regulates multiple processes that significantly contribute to the lupus-related pathology by controlling the production of IL-2 and IL-17 by T cells, the proliferation of mesangial cells, and the function and structure of podocytes. CaMK4 is also upregulated in podocytes from patients with focal segmental glomerulosclerosis (FSGS). In both immune and non-immune podocytopathies, CaMK4 disrupts the structure and function of podocytes.

View Article and Find Full Text PDF
Article Synopsis
  • Podocyte dysfunction is linked to both autoimmune and nonautoimmune kidney diseases, with calcium signaling playing a critical role in this process.
  • Research has shown that CaMK IV (CaMK4) expression increases in podocytes from patients with lupus nephritis and from certain animal models, influencing motility and reducing important structural proteins.
  • Inhibiting CaMK4 specifically in podocytes can protect against kidney damage and preserve their function, suggesting potential therapeutic benefits for conditions like lupus nephritis and focal segmental glomerulosclerosis.
View Article and Find Full Text PDF

Pulmonary alveolar proteinosis (PAP) is a rare lung syndrome caused by the accumulation of surfactants in the alveoli. The most prevalent clinical form of PAP is autoimmune PAP (aPAP) whereby IgG autoantibodies neutralize GM-CSF. GM-CSF is a pleiotropic cytokine that promotes the differentiation, survival, and activation of alveolar macrophages, the cells responsible for surfactant degradation.

View Article and Find Full Text PDF